• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    GraniteShares Launches ISRG and NBIS Leveraged Single-Stock ETFs: ISUL & NBIL

    10/7/25 8:00:00 AM ET
    $ISRG
    $NBIS
    Industrial Specialties
    Health Care
    Computer Software: Programming Data Processing
    Technology
    Get the next $ISRG alert in real time by email

    New York, Oct. 07, 2025 (GLOBE NEWSWIRE) -- GraniteShares 2x Long ISRG Daily ETF (ISUL) and GraniteShares 2x Long NBIS Daily ETF (NBIL) Launch Today.

    GraniteShares, a provider of exchange traded funds (ETFs), today announced the launch of two new leveraged single-stock ETFs:

    GraniteShares 2x Long ISRG Daily ETF (NASDAQ:ISUL), and

    GraniteShares 2x Long NBIS Daily ETF (NASDAQ:NBIL)

    An investment in these ETFs provides investors daily leveraged exposure to the two respective underlying stocks: Intuitive Surgical, Inc. (NASDAQ:ISRG) and Nebius Group NV (NASDAQ:NBIS).

    GraniteShares' leveraged ETFs seek daily investment results, before fees and expenses, that correspond to 2 times (200%) the daily percentage change of the respective common stocks. These funds are designed for investors looking to capitalize on short-term movements in the underlying stocks.

     New GraniteShares 2x Leveraged Single-Stock ETFs

    TickerFund NameFund Page URL
    ISULGraniteShares 2x Long ISRG Daily ETFhttps://graniteshares.com/institutional/us/en-us/etfs/isul/
    NBILGraniteShares 2x Long NBIS Daily ETFhttps://graniteshares.com/institutional/us/en-us/etfs/nbil/

     

    Underlying Companies

    • Intuitive Surgical, Inc., (NASDAQ:ISRG) founded in 1995 and based in Sunnyvale, California, develops and markets robotic-assisted technologies that advance minimally invasive care. Its flagship da Vinci Surgical System supports procedures across specialties such as general surgery, urology, gynecology, cardiothoracic, and head and neck, while the Ion endoluminal system enables minimally invasive lung biopsies and extends its reach into diagnostic procedures. The company also provides stapling, energy, and core instruments, training programs, technical support, system monitoring, and digital solutions that enhance hospital performance. Its products are sold worldwide through direct capital and clinical sales teams.



    • Nebius Group N.V., (NASDAQ:NBIS) headquartered in Amsterdam and rebranded from Yandex N.V. in 2024, is a Netherlands-based technology company building full-stack infrastructure for the global AI industry. Its offerings include GPU clusters, cloud platforms, and developer tools supporting AI workloads like generative AI and autonomous vehicles. The company also operates three brands: Toloka for AI data services, TripleTen for tech career reskilling, and Avride for autonomous driving and robotics, serving markets across Europe, North America, and Israel.



    Designed for Tactical Traders

    The new leveraged ETFs provide traders with a tool to gain leveraged exposure to these stocks, making them a potential consideration for those looking to execute short-term tactical trades.

    "We continue to expand our suite of leveraged ETFs to meet the demand for high-conviction trading opportunities," said Will Rhind, Founder of GraniteShares. "With the launch of ISUL, and NBIL, we are providing investors with targeted tools to access some of the most exciting companies in financial services, online brokerage and digital investing."

    For more information on the new GraniteShares leveraged ETFs, read the Prospectus.

    About GraniteShares

    GraniteShares is an entrepreneurial ETF provider focused on high-conviction investment solutions. The firm offers a range of innovative ETFs spanning leveraged, inverse, and high-yield strategies, empowering investors with differentiated tools for portfolio construction. Founded in 2016, GraniteShares has grown rapidly by delivering cutting-edge solutions tailored to modern market needs. For more information, visit www.graniteshares.com.

    Media Contact:

    GraniteShares Inc.

    Attn: Media Relations

    222 Broadway, 21st Floor

    New York, NY 10038

    844-476-8747

    [email protected]

    RISK FACTORS AND IMPORTANT INFORMATION

    This material must be preceded or accompanied by a Prospectus. Carefully consider the Fund's investment objectives risk factors, charges and expenses before investing. Please read the prospectus before investing. The fund does not directly invest in the underlying stock.

    The Fund is recently organized October 07, 2025. As a result, prospective investors do not have a track record or history on which to base their investment decisions. There can be no assurance that the Funds will grow to or maintain an economically viable size.

    The Fund is not suitable for all investors. The investment program of the funds is speculative, entails substantial risks and include asset classes and investment techniques not employed by most ETFs and mutual funds. Investments in the ETFs are not bank deposits and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency. The Fund is designed to be utilized only by knowledgeable investors who understand the potential consequences of seeking daily leveraged (2X) investment results, understand the risks associated with the use of leverage and are willing to monitor their portfolios frequently. For periods longer than a single day, the Fund will lose money if the Underlying Stock's performance is flat, and it is possible that the Fund will lose money even if the Underlying Stock's performance increases over a period longer than a single day. An investor could lose the full principal value of his/her investment within a single day.

    The Fund seeks daily leveraged investment results and are intended to be used as short-term trading vehicles. This Fund attempts to provide daily investment results that correspond to the respective long leveraged multiple of the performance of its underlying stock (a Leverage Long Fund).

    Investors should note that such Leverage Long Fund pursues daily leveraged investment objectives, which means that the Fund is riskier than alternatives that do not use leverage because the Fund magnifies the performance of its underlying stock. The volatility of the underlying security may affect a Funds' return as much as, or more than, the return of the underlying security.

    Because of daily rebalancing and the compounding of each day's return over time, the return of the Fund for periods longer than a single day will be the result of each day's returns compounded over the period, which will very likely differ from 200% of the return of the Underlying Stock over the same period. The Fund will lose money if the Underlying Stock's performance is flat over time, and as a result of daily rebalancing, the Underlying Stock volatility and the effects of compounding, it is even possible that the Fund will lose money over time while the Underlying Stock's performance increases over a period longer than a single day.

    Shares are bought and sold at market price (not NAV) and are not individually redeemed from the ETF. There can be no guarantee that an active trading market for ETF shares will develop or be maintained, or that their listing will continue or remain unchanged. Buying or selling ETF shares on an exchange may require the payment of brokerage commissions and frequent trading may incur brokerage costs that detract significantly from investment returns.

    An investment in the Fund involves risk, including the possible loss of principal. The Fund is non-diversified and includes risks associated with the Fund concentrating its investments in a particular industry, sector, or geographic region which can result in increased volatility. The use of derivatives such as futures contracts and swaps are subject to market risks that may cause their price to fluctuate over time. Risks of the Fund include Effects of Compounding and Market Volatility Risk, Leverage Risk, Market Risk, Counterparty Risk, Rebalancing Risk, Intra-Day Investment Risk, Other Investment Companies (including ETFs) Risk, and risks specific to the securities of the Underlying Stock and the sector in which it operates. These and other risks can be found in the prospectus.

    This information is not an offer to sell or a solicitation of an offer to buy shares of any Funds to any person in any jurisdiction in which an offer, solicitation, purchase or sale would be unlawful under the securities laws of such jurisdiction. Please consult your tax advisor about the tax consequences of an investment in Fund shares, including the possible application of foreign, state, and local tax laws. You could lose money by investing in the ETFs. There can be no assurance that the investment objective of the Funds will be achieved. None of the Funds should be relied upon as a complete investment program.

    The Fund is distributed by ALPS Distributors, Inc, which is not affiliated with GraniteShares or any of its affiliates ©2025 GraniteShares Inc. All rights reserved. GraniteShares, GraniteShares Trusts, and the GraniteShares logo are registered and unregistered trademarks of GraniteShares Inc., in the United States and elsewhere. All other marks are the property of their respective owners.



    Primary Logo

    Get the next $ISRG alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ISRG
    $NBIS

    CompanyDatePrice TargetRatingAnalyst
    Nebius Group N.V.
    $NBIS
    9/15/2025Neutral
    Seaport Research Partners
    Intuitive Surgical Inc.
    $ISRG
    7/23/2025Buy → Hold
    Erste Group
    Nebius Group N.V.
    $NBIS
    7/14/2025$68.00Buy
    Goldman
    Intuitive Surgical Inc.
    $ISRG
    6/9/2025$440.00Hold → Sell
    Deutsche Bank
    Nebius Group N.V.
    $NBIS
    6/5/2025$84.00Buy
    Arete
    Intuitive Surgical Inc.
    $ISRG
    6/5/2025Hold → Buy
    Erste Group
    Nebius Group N.V.
    $NBIS
    5/6/2025$34.00Outperform
    Northland Capital
    Nebius Group N.V.
    $NBIS
    2/25/2025$50.00Buy
    DA Davidson
    More analyst ratings

    $ISRG
    $NBIS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ladd Amy L sold $305,588 worth of shares (671 units at $455.42), decreasing direct ownership by 48% to 739 units (SEC Form 4)

    4 - INTUITIVE SURGICAL INC (0001035267) (Issuer)

    9/4/25 6:55:00 PM ET
    $ISRG
    Industrial Specialties
    Health Care

    Executive Chair of the Board o Guthart Gary S exercised 36,000 shares at a strike of $79.64 and sold $13,872,227 worth of shares (29,360 units at $472.49), increasing direct ownership by 50% to 19,827 units (SEC Form 4)

    4 - INTUITIVE SURGICAL INC (0001035267) (Issuer)

    9/2/25 4:16:29 PM ET
    $ISRG
    Industrial Specialties
    Health Care

    Executive Chair of the Board o Guthart Gary S exercised 7,893 shares at a strike of $59.46, sold $5,322,419 worth of shares (10,693 units at $497.75) and gifted 10,500 shares (SEC Form 4)

    4 - INTUITIVE SURGICAL INC (0001035267) (Issuer)

    7/29/25 1:02:33 PM ET
    $ISRG
    Industrial Specialties
    Health Care

    $ISRG
    $NBIS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    GraniteShares Launches ISRG and NBIS Leveraged Single-Stock ETFs: ISUL & NBIL

    New York, Oct. 07, 2025 (GLOBE NEWSWIRE) -- GraniteShares 2x Long ISRG Daily ETF (ISUL) and GraniteShares 2x Long NBIS Daily ETF (NBIL) Launch Today. GraniteShares, a provider of exchange traded funds (ETFs), today announced the launch of two new leveraged single-stock ETFs:GraniteShares 2x Long ISRG Daily ETF (NASDAQ:ISUL), and GraniteShares 2x Long NBIS Daily ETF (NASDAQ:NBIL) An investment in these ETFs provides investors daily leveraged exposure to the two respective underlying stocks: Intuitive Surgical, Inc. (NASDAQ:ISRG) and Nebius Group NV (NASDAQ:NBIS). GraniteShares' leveraged ETFs seek daily investment results, before fees and expenses, that correspond to 2 times (200%) the

    10/7/25 8:00:00 AM ET
    $ISRG
    $NBIS
    Industrial Specialties
    Health Care
    Computer Software: Programming Data Processing
    Technology

    Jupiter Endovascular Closes Oversubscribed Series B Financing, Surpassing $40 Million Target

    Round Led by Sonder Capital with Participation from Senvest Management, LB Investment, and a New Strategic Corporate Investor Jupiter Endovascular, Inc., a medical technology startup developing a new class of endovascular procedures using its proprietary Transforming Fixation (TFX) technology, today announced it has closed an oversubscribed Series B financing that surpassed its $40 million target. The round was led by Sonder Capital, with participation from Senvest Management, LB Investment, and a new strategic corporate investor. The proceeds will be used to complete Jupiter's ongoing SPIRARE II pivotal clinical trial, prepare for commercialization, and develop new clinical applications

    10/7/25 8:00:00 AM ET
    $ISRG
    $PRCT
    Industrial Specialties
    Health Care
    Medical/Dental Instruments

    Nebius Group announces exercise of the underwriters' option to purchase additional Class A shares

    Nebius Group N.V. (("Nebius Group" or the "Company", NASDAQ:NBIS), a leading AI infrastructure company, today announced that, in connection with its previously announced underwritten public offering of Class A ordinary shares, the underwriters have exercised in full their option to purchase an additional 1,621,621 Class A shares at the offering price of $92.50, less underwriting discounts and commissions, bringing Nebius's aggregate gross proceeds from the Class A offering to approximately $1.15 billion. The initial closing of the Class A offering occurred on September 15, at which time the Company also closed its offering of convertible notes due 2030 and 2032 to qualified institutional bu

    9/22/25 11:13:00 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    $ISRG
    $NBIS
    SEC Filings

    View All

    SEC Form 6-K filed by Nebius Group N.V.

    6-K - Nebius Group N.V. (0001513845) (Filer)

    9/22/25 9:34:48 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    SEC Form 6-K filed by Nebius Group N.V.

    6-K - Nebius Group N.V. (0001513845) (Filer)

    9/15/25 3:47:35 PM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    SEC Form FWP filed by Nebius Group N.V.

    FWP - Nebius Group N.V. (0001513845) (Subject)

    9/11/25 6:26:17 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    $ISRG
    $NBIS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Seaport Research Partners initiated coverage on Nebius Group N.V.

    Seaport Research Partners initiated coverage of Nebius Group N.V. with a rating of Neutral

    9/15/25 8:09:01 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    Intuitive Surgical downgraded by Erste Group

    Erste Group downgraded Intuitive Surgical from Buy to Hold

    7/23/25 8:54:24 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    Goldman initiated coverage on Nebius Group N.V. with a new price target

    Goldman initiated coverage of Nebius Group N.V. with a rating of Buy and set a new price target of $68.00

    7/14/25 8:52:56 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    $ISRG
    $NBIS
    Leadership Updates

    Live Leadership Updates

    View All

    Marc Boroditsky Joins Nebius as Chief Revenue Officer

    Nebius (NASDAQ:NBIS), a leading AI infrastructure company, today announced the appointment of Marc Boroditsky as Chief Revenue Officer as the company continues to build out its global sales team. A seasoned senior tech executive, Marc has a strong global go-to-market track record of driving high growth – in five years at Twilio he grew paying customers six times, and revenue more than 10 times to $4 billion. Previously he founded several successful companies, and served as a senior leader at Oracle and most recently Cloudflare. Arkady Volozh, founder and CEO of Nebius, welcomed Marc to the company: "We are building a global company and planning to grow many times in the coming years.

    5/28/25 7:30:00 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    30 years of Innovation and Impact: Dan Larson's Inspiring Story

    SUNNYVALE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- When Seattle resident Dan Larson was diagnosed with lung cancer in 2023, his only exposure to robotic technology was through his work as a quality engineer at Boeing. He could never have imagined that robotic technology made by Intuitive, the pioneer of robotic-assisted surgery, would one day play a pivotal role in his health care. Having experienced the loss of his father to lung cancer, Dan was determined to overcome his own diagnosis and enjoy his retirement with his family. Under the care of clinicians at MultiCare Tacoma General Hospital in Washington, Dan underwent two robotic lung biopsies with the Ion Endoluminal System, Intuit

    5/27/25 9:15:00 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    Intuitive Announces CEO Transition Effective July 1, 2025

    President Dave Rosa promoted to CEOCurrent CEO Gary Guthart to become executive chair of Intuitive's boardCurrent Board Chair Craig Barratt to become lead independent director SUNNYVALE, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the promotion of President Dave Rosa to chief executive officer, effective July 1, 2025. At that time, current CEO Gary Guthart will become the executive chair of Intuitive's board of directors, and current Board Chair Craig Barratt will become lead independent director. Guthart will work closely with Rosa to support a smooth t

    5/15/25 9:05:00 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    $ISRG
    $NBIS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Nebius Group N.V.

    SC 13G/A - Nebius Group N.V. (0001513845) (Subject)

    11/12/24 10:32:14 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    SEC Form SC 13G/A filed by Intuitive Surgical Inc. (Amendment)

    SC 13G/A - INTUITIVE SURGICAL INC (0001035267) (Subject)

    2/14/24 10:02:59 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Intuitive Surgical Inc. (Amendment)

    SC 13G/A - INTUITIVE SURGICAL INC (0001035267) (Subject)

    2/14/23 12:37:59 PM ET
    $ISRG
    Industrial Specialties
    Health Care

    $ISRG
    $NBIS
    Financials

    Live finance-specific insights

    View All

    Report Highlights Growth in AI Biomarker Monitoring as Industry Giant's GPUs Power Next-Gen Platform

    MarketNewsUpdates News Commentary NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The global Diagnostic Biomarker market is experiencing unprecedented growth and is projected to continue to see substantial growth in years to come. A recent report from the (NIH) National Library of Medicine discussed the AI-Assisted Biomarker, said that: "Recently, advancements in healthcare digitization and personalized treatments have led to groundbreaking developments. Utilization of AI and ML has the potential to enhance comprehension of disease onset and progression, potentially uncovering new disease subtypes, unveiling novel drug targets, advancing the field of precision medicine, propelling efforts towards d

    9/11/25 8:45:00 AM ET
    $APLD
    $NBIS
    $NVDA
    Finance: Consumer Services
    Finance
    Computer Software: Programming Data Processing
    Technology

    Nebius Reports Second Quarter Financial Results and Raises ARR Guidance for 2025

    Annualized run-rate revenue(1) (ARR) guidance increased to $900 million to $1.1 billion for the end of 2025 Revenue for Q2 of $105.1 million, up 625% year-on-year and 106% quarter-on-quarter Core business achieves positive Adjusted EBITDA ahead of plan In the process of securing more than 1 GW of power by the end of 2026 Nebius Group N.V. (NASDAQ:NBIS), a leading AI infrastructure company, today announced its unaudited financial results for the second quarter ended June 30, 2025. "Nebius is continuing to deliver exceptional results," said founder and CEO Arkady Volozh. "In Q2 we more than doubled revenue from the previous quarter, and our core business achieved positive Adjus

    8/7/25 8:58:00 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    Intuitive Announces Second Quarter Earnings

    SUNNYVALE, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended June 30, 2025. Q2 Highlights Worldwide da Vinci procedures grew approximately 17% compared with the second quarter of 2024.The Company placed 395 da Vinci surgical systems, compared with 341 in the second quarter of 2024. The second quarter 2025 da Vinci surgical system placements included 180 da Vinci 5 systems, compared with 70 in the second quarter of 2024.The Company grew its da Vinci surgical system installed base to 10,488 systems as of

    7/22/25 4:05:00 PM ET
    $ISRG
    Industrial Specialties
    Health Care